Clinical Trial (Interventional)

Results 376 - 400 of 403
Public Title Project Description Modified
A 52-week, multicenter, randomized, double-blind, double dummy, parallel-group, placebo-controlled . . . This study uses a randomized, multicenter, double-blind, double-dummy, placebocontrolled, parallel- . . . 30 Nov -0001 12:00:00
A Phase 2a Open-Label Study in Infants with REspiratory Syncytial VIRus Lower RespirAtory Tract Infe . . . REVC003 is a phase 2a open-label study in infants with RSV lower respiratory tract infection (LRTI), . . . 20 Jun 2019 02:52:41
A Phase III, Randomized, Multi-Center, Double-Blind, Global Study to Determine the Efficacy and Safe . . . This is a randomized, double-blind, placebo controlled, multi-center, global, Phase III study to det . . . 24 Apr 2019 01:23:42
A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up . . . This is a multicenter, randomized, double-blind, placebo controlled, parallel group study with two s . . . 18 Jun 2019 10:16:53
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to less than 4 Years . . . SP0967 is a Phase 3, multicenter, double-blind, randomized, PBO-controlled, parallel-group study to . . . 28 Jun 2019 03:46:30
Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children with Partial On . . . EP0034 is a Phase 3, multicenter, open-label, extension study to obtain long-term safety and efficac . . . 20 Jun 2019 05:14:14
A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up . . . This is a multicenter, randomized, double-blind, placebo controlled, parallel group study with two . . . 28 May 2019 08:01:56
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HC . . . This is a multicenter, randomized, open-label, controlled Phase 3 trial of cabozantinib in combinati . . . 25 Jun 2019 05:58:10
A 12-week phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and . . . This study uses a single-cohort, 2-treatment arms, randomized (1:1 (70 mg:placebo)), double-blind st . . . 20 Jun 2019 05:03:36
A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclit . . . This is a Phase III, double-blind, randomised study assessing the efficacy of capivasertib + paclita . . . 01 Aug 2019 11:08:02
Application of Stem Cells for Diabetic Foot Wounds The study hypothesizes that application of Umbilical Cord derived Mesenchymal Stem Cells (UC-MSCs) i . . . 09 Jul 2019 08:37:09
Debio 1347-201 – Phase II basket trial in solid tumors harboring a fusion of FGFR1-3 Multicentre, basket, two stage, adaptive single arm Phase II study in subjects with solid tumors har . . . 24 Jul 2019 11:13:04
A prospective, open-label, interventional phase IV study to assess the safety of EupentaTM Inj. {ful . . . This is a prospective, open-label, single-arm, interventional phase IV study to assess the safety of . . . 20 Sep 2019 08:36:18
A Regional, Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study . . . Tezepelumab is in development for the treatment of severe asthma. A proof-of-concept study (Gauvreau . . . 25 Jul 2019 12:24:43
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in . . . This is the second study in support of the pediatric development of IMI/REL (imipenem/cilastatin/re . . . 31 Jul 2019 11:29:09
Effects of Brown Rice Consumption on the Metabolic Risk Factors of Non–Communicable Diseases in Se . . . The study aimed to evaluate the effects of brown rice consumption on the metabolic risk factors of N . . . 25 Jul 2019 06:45:29
A Phase 3, Randomized, Multicenter, Open-Label, Controlled Study to Evaluate the Efficacy and Safety . . . This is a prospective, randomized, multi-center, open-label, controlled study. Following screening, . . . 08 Aug 2019 10:15:57
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospit . . . This regional study (PN016) is the second pivotal HABP/VABP study, to allow sufficient enrollment of . . . 14 Aug 2019 11:07:53
A Randomized, Double-blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the . . . A Randomized, Double-blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the . . . 16 Oct 2019 01:30:25
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK8835/PF-04971729) (MK-8835-059) This study will evaluate the safety and efficacy of ertugliflozin (MK8835) in pediatric participants . . . 13 Sep 2019 03:53:27
A Multi-center, Randomized, Active-controlled, Parallel-group, Open-label and Phase II Study to Eval . . . Planned duration of the study (for each subject): About 32 weeks; Total 336 subjects ( Randomized 1: . . . 10 Oct 2019 05:01:46
Lupus Study Systemic lupus erythematosus is a chronic, often debilitating, multisystem, autoimmune diseasethat i . . . 30 Sep 2019 05:00:47
A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 . . . This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter, Phase 3 study t . . . 30 Sep 2019 02:53:48
A Phase 2b Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in P . . . This is a Phase 2b, double blinded, randomized study of SYN023 compared to HyperRab® S/D (a license . . . 30 Sep 2019 02:56:56
A Phase 2 Study of Cemdisiran in Adult Patients with IgA Nephropathy This is a multicenter, double-blind, placebo-controlled study comprised of three periods. The first . . . 07 Oct 2019 04:38:27

Copyright © One Window Project 2018. All rights reserved.